Adar Poonawalla Acquires London’s Second-Most Expensive Home for £138 Million

The ‘Vaccine Prince’ Makes London’s Priciest Purchase

Adar Poonawalla, famously known as the ‘vaccine prince,’ seals a deal to acquire Aberconway House, a 25,000-square-foot Mayfair mansion near Hyde Park, for approximately £138 million.

This purchase marks London’s most expensive home sale of the year.

London’s Luxurious Real Estate Market

The acquisition of Aberconway House places it as the second-most expensive property ever sold in London.

The transaction, completed with Dominika Kulczyk, daughter of Poland’s wealthiest man, positions it as a highlight in the city’s real estate, surpassing other significant sales in the luxury property market.

Noteworthy Property Deals in London

While this purchase claims the spotlight as the year’s largest deal, it follows the £113 million acquisition of Hanover Lodge.

The city’s most expensive sale remains the £210 million sale of 2-8a Rutland Gate in 2020, emphasizing London’s allure for high-net-worth international investors.

Attraction of Elite Properties Amid Market Trends

Despite adjustments targeting international money in the housing market, elite properties in London retain their appeal for global buyers.

While the housing market slows for mortgage-dependent buyers, these high-end acquisitions continue to showcase the city’s allure for international investors.

Aberconway House: A Storied Residence

The historic red-brick Aberconway House, previously rented by Mr. Poonawalla for over £50,000 a week in 2021, boasts a rich heritage tied to Henry Duncan McLaren, known as Baron Aberconway.

The property serves as a significant acquisition for the Poonawalla family’s business and occasional UK residence.

Investments in Vaccine Research and Contributions

Beyond real estate, Mr. Poonawalla’s company has made substantial investments in vaccine research and manufacturing facilities near Oxford. Their contributions to Oxford University’s vaccine research building and their role in producing millions of doses of the Oxford/AstraZeneca vaccine underline their commitment to the healthcare sector.

Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn